Evotec to Launch its First Innovation Centre for Fragment Based Drug Discovery
Evotec has established a scientific advisory board of eminent scientists for this Innovation Centre to advise on the selection of high quality biological targets for Evotec's pipeline of projects for partnering as well as advising on the development of the programmes and to identify areas to further enhance the technology base. Its members include Professor Sir Ravinder Nath "Tiny" Maini, recently retired as the Director of the Kennedy Research Institute at Imperial College London, Professor Peter Ratcliffe, Nuffield Professor of Medicine and Head of Department at the University of Oxford, Professor David Kerr, Rhodes Professor of Clinical Pharmacology and Cancer Therapeutics at the Department of Clinical Pharmacology, University of Oxford, Professor Dame Louise Johnson, David Phillips Professor of Molecular Biophysics at Oxford and Dr Michael Sundstrom, leader of the Structural Genomics Consortium operations in Oxford, UK.
Over the next two years Evotec plans to create a number of Innovation Centres in key areas that will bring new innovative solutions for the identification of therapeutic products for the pharmaceutical industry. The Centres will combine existing capabilities and expertise within Evotec with external scientific and technical expertise and investment.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.